Is apoptosis a massive process in myelodysplastic syndromes?

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 368-371

  Lepelley, Pascale ^a   Campergue, Laurence ^a   Grardel, Nathalie ^a   Preudhomme, Claude ^a   Cosson, Alain ^a   Fenaux, Pierre ^a  

^a UNIV LILLE   (France)

Author keywords

Apoptosis; Fas antigen; Myelodysplastic syndromes

Indexed keywords

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CYTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0029804412     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1915.x     Document Type: Article

References (11)

1. Bennett. J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology. 51, 189-199.
2. Gavrieli, Y., Sherman, Y. & Ben Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling in nuclear DNA fragmentation. Journal of Cell Biology, 119, 493-501.
3. Gorczyca, W., Gong. J. & Darzynkiewicz, Z. (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Research, 53, 1945-1951.
4. Greenberg, N., Ginzton, N., Rajanaska, R., Tong, C.R. & Han, J.H. (1993) Apoptosis in myelodysplastic syndrome (MDS). (Abstract). Blood, 82, (Suppl. 1), 159a.
5. Hatake, K., Tomizuka, H., Ikeda, M., Tsunoda, J.I., Hoshino, Y., Ohtsuki, T., Kasahara, T., Yonehara, S. & Miura, Y. (1994) The presence of apoptosis in refractory anemia of myclodysplasia. Molecular Biology of Haematopoiesis, 3, 127-133.
6. Kanter. L., Hellstrom-Lindberg, E., Kock, Y., Rodensjo. M. & Ost, A. (1995) Erythropoietic effectiveness and apoptosis in patients with myelodysplastic syndromes (MDS) treated with G-CSF and EPO. (Abstract). Blood, 86, (Suppl. 1), 338a.
7. 2+ -independent endonuclease activity capable of producing nucleosomal-size DNA fragmentation in non-adherent marrow mononuclear cells from patients with myelodysplastic syndromes and acute myelogenous leukemia. Leukemia, 10, 67-73.
8. Lepelley, P., Preudhomme, C., Vanrumbeke, M., Quesnel, B., Cosson, A. & Fenaux, P. (1994) Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia. 8, 1342-1349.
9. Oscier, D. (1987) Myelodysplastic syndromes. Baillière's Clinical Haematology. 1, 389-426.
10. Raza, A., Gezer, S., Mundie, S. , Gao, X.F., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V. Parcharidou, A., Loew, J., Marcus, R., Khan, Z., Chaney, C., Showel. J., Gregory, S. & Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268-276.
11. Yuan, J., Angelucci, E., Lucarelli, G., Aljurf, M., Snyder, L.M., Kiefer, C.R., Ma, L. & Schrier, S.I., (1993) Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia). Blood, 82, 374-377.